0000744218 2026-06-25 2026-06-25 0000744218 1 2026-06-25 2026-06-25 iso4217:USD pure shares S-8 S-8 EX-FILING FEES 0000744218 Celldex Therapeutics, Inc. N/A false S-8 Celldex Therapeutics, Inc. Equity Common Stock, $0.001 par value per share true 3400000 32.86 111724000.00 0.0001381 15429.08 111724000.00 15429.08 0.00 15429.08 (1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of the Company's common stock that become issuable under the Company's 2021 Omnibus Equity Incentive Plan (the "Plan") in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Company's receipt of consideration that increases the number of the outstanding shares of the Company's common stock. (2) Pursuant to Rules 457(c) and (h) under the Securities Act, the proposed maximum offering price per share and the proposed maximum aggregate offering price are estimated for the purpose of calculating the amount of the registration fee and are based on the average of the high and low sales price of the Company's common stock as reported on the NASDAQ Stock Market on June 22, 2026. (3) The Registrant does not have any fee offsets.